[1]
A. Khasbazar, S. Ruvjir, B. Yalhgar, T. Altankhuyag, and B. Oidov, “Comparison of Adverse Events Between Selective Internal Radiation Therapy Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma in Mongolia: A Subgroup Analysis of SIRveNIB Study”, Cent. Asian j. Med. Sci., vol. 3, no. 3, pp. 297–305, Nov. 2017.